The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 12 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Gurley: Equal VC partnerships eliminate political overhead and align partner incentives
“The second one is, it really encourages development of the new people that come in, because I'm gonna take an equal part of their success when they start delivering, and so I'm not, I want them to be super successful, and I'm gonna spend time, and I, boy, on m…”
Tavel: Benchmark deliberately limits itself to five equal GPs and no delegation
“At Benchmark, our model of investing is that we have decided that we're not going to scale our business. You know, we haven't grown our fund size, and it's just five general partners right now, and it's a kind of this rare structure of an equal partnership. An…”
Tavel: Unlike other firms, Benchmark GPs conduct executive talent calls directly
“I'm on, you know, seven boards right now, and I am on these talent calls every week for some of my companies where we're doing a search for a CRO as an example, and it will always be me and then the talent partners of the other firms as opposed to the partner …”
Tavel: Efficient startups should burn aggressively to pull away from competitors
“If you have a more efficient machine where you're able to, again, take that dollar and make, you know, five dollars, six dollars, whatever it may be out of it, if not more, then you should be burning as much money as you can do efficiently to keep getting furt…”
Tavel: Chainalysis Achieved Winner-Take-Most Dominance Without Explicit Network Effects
“And so chain analysis has become this de facto standard in the space. It just got into a space before other people saw the opportunity And because they were the leader, they were able to build more and more technology. You know, they're able to go across any b…”
Housel: Widespread Mutual Fund Underperformance Is Natural and Statistically Expected
“It's the same in investing. Like, there should not be a world in which every ambitious stock picker can beat the market. Of course, whenever you hear the statistics about 95% of mutual funds underperform their benchmark, I'm like, yeah, what would you expect?”
Tavel: Venture Investment Memos Work as Deductive Philosophical Logic Proofs
“And I think investing is the same thing. Like when you're writing an investment recommendation or thinking about a potential investment, you also, you know, really what it comes down to is, is a proof in the same way where you have the premises, which may be a…”
Tavel: Postponing difficult management decisions creates compounding organizational damage
“And what I always remind founders is that pain today postponed until tomorrow is going to be harder. It's like taking a loan out on the pain. And particularly in the early stages of a company, if you have the wrong head of product, And you know it, but you're …”
Tavel: Founder ambition often causes failure by avoiding narrow market focus
“For the failure scenarios, a founder's ambition blinds them in not picking a small starting place to really, really execute and get incredibly strong product market fit. Their ambition blinds them to wanting to take on A really big problem with a blunt product…”
Tavel: Board members lose founder trust by poaching, investing in competitors, or self-optimizing
“The other way that happens from where the board loses the CEO's trust is usually if the CEO doesn't feel like the board member is acting in the best interest of the company. If an investor ends up investing in a competitive company, if they recruit someone to …”
Tavel: Founders must deliver bad news to boards immediately to avoid breaking trust
“You know, one of the things that I tell my companies is you can take as long to, you can wait until the board meeting to give good, you know, good news, but you give bad news as fast as possible. And there's, that is a classic trust breakdown from the founder …”
Tavel: Benchling succeeded by spotting overlooked biologics market tailwinds
“We have another company called Benchling that has just done a phenomenal job executing in this kind of biologic space, which again, there was a current that they saw that other people didn't see that was creating this really, really big market, but in the begi…”